FDA authorizes first commercial monkeypox test, pertussis vaccine for young infants
![aha-today-maternal-health-900x400](/sites/default/files/styles/900x400/public/2018-10/aha-today-maternal-health-900x400.jpg?itok=CdxHH8X3)
The Food and Drug Administration Friday authorized for emergency use the first commercial test kit to detect monkeypox in lesion swab specimens. Only laboratories certified under the Clinical Laboratory Improvement Amendments to perform moderate or high complexity tests are authorized to perform the Abbott Molecular test.
In other news, the FDA approved the first vaccine to administer to mothers during pregnancy to prevent whooping cough (pertussis) in infants under two months old. The Boostrix vaccine previously was approved to protect pregnant women, adults and children age 10 and older.
Related News Articles
Headline
The World Health Organization Aug. 14 declared a global health emergency due to the recent mpox outbreak in Africa, the second mpox declaration in two years.…
Headline
The results of a study published July 16 by JAMA Network Open showed a 19% increase in postpartum primary care provider visits for patients through the use of…
Headline
Kittitas Valley Healthcare, based in Ellensburg, Wash., was delivering 300-350 babies each year in the region prior to 2022, offering the area’s only…
Headline
An infographic released by the University of Minnesota Rural Health Research Center highlights the decline of maternity care access in rural counties across…
Headline
The Health Resources and Services Administration June 11 announced that Montana is eligible for $5.4 million in federal funding this year for the Maternal,…
Headline
The award-winning Beyond Birth podcast series helps bring hospital programs to life by telling personal stories of how they positively impact mothers and their…